Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 9.

Zhou, T; Georgeon, S; Moser, R; Moore, D J; Caflisch, A; Hantschel, O (2014). Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348). Leukemia, 28(2):404-407.

Zhou, T; Lafleur, K; Caflisch, A (2010). Complementing ultrafast shape recognition with an optical isomerism descriptor. Journal of Molecular Graphics and Modelling, 29(3):443-449.

Zhou, T; Caflisch, A (2010). High-throughput virtual screening using quantum mechanical probes: discovery of selective kinase inhibitors. ChemMedChem, 5(7):1007-1014.

Huang, D; Zhou, T; Lafleur, K; Nevado, C; Caflisch, A (2010). Kinase selectivity potential for inhibitors targeting the ATP binding site: A network analysis. Bioinformatics, 26(2):198-204.

Zhou, T; Huang, D; Caflisch, A (2010). Quantum mechanical methods for drug design. Current Topics in Medicinal Chemistry, 10(1):33-45.

Bodenreider, C; Beer, D; Keller, T H; Sonntag, S; Wen, D; Yap, L; Yau, Y H; Shochat, S G; Huang, D; Zhou, T; Caflisch, A; Su, X C; Ozawa, K; Otting, G; Vasudevan, S G; Lescar, J; Lim, S P (2009). A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease. Analytical Biochemistry, 395(2):195-204.

Zhou, T; Caflisch, A (2009). Data management system for distributed virtual screening. Journal of Chemical Information and Modeling, 49(1):145-152.

Lafleur, K; Huang, D; Zhou, T; Caflisch, A; Nevado, C (2009). Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4). Journal of Medicinal Chemistry, 52(20):6433-6446.

Zhou, T; Huang, D; Caflisch, A (2008). Is quantum mechanics necessary for predicting binding free energy? Journal of medicinal chemistry, 51(14):4280-4288.

This list was generated on Mon Apr 22 22:01:55 2019 CEST.